Taken together, USP37 upregulation was involved in adriamycin resistance of breast cancer cells, and USP37 might be a prospective therapeutic biological marker for monitoring and overcoming breast cancer adriamycin resistance. The gene discussed is USP37; the disease is breast cancer.